U.S. Virology and Bacteriology Market for over 100 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

This new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
 
Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.
  
Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation,
  reagents kits, IT and other products with significant market
  appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus, Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

- Sales and market shares of major suppliers
  by individual test.

- Volume and sales forecasts for over 100 infectious disease
   assays by individual test and market segment:

     ° Hospitals
     ° Blood Banks
     ° Commercial/Private Laboratories
     ° Physician Offices/Group Practices
     ° Public Health Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics,
   culture/microscopy).

- Review of the market dynamics, trends,
  structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of over 100 major diseases,
  including their etiology, current diagnostic tests,
  vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
  testing, including their operating
  characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,
  immunoassay, and other technologies and their potential
  applications for infectious disease testing.

- Global listings of companies developing or
  marketing infectious disease diagnostic products
  by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
  emerging market entrants, including their sales, product
  portfolios, marketing tactics, collaborative
  arrangements and new products in R&D.



I. Introduction
II. Worldwide Market Overview
A. Business Environment
B. Market Structure
C. Market Size and Growth
III. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. Worldwide Overview of Major Tests,
Technologies, and Instrumentation
A. Major Infectious Disease Tests

1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT,
Western Blot, HTLV-I/II
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA)
and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Chagas Disease
13. Chancroid
14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakobs Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori

33. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies
53. Respiratory Syncytial Virus (RSV)
54. Rhinoviruses
55. Rotavirus
56. Rubella
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina


B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semiautomated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
VIII. U.S.A. Infectious Disease Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume
and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
IX. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin

- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List Of Tables


Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus
Tests
Major Companies Developing or Marketing Bartonella
Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida
Tests
Major Companies Developing or Marketing Chlamydia
Tests
Major Companies Developing or Marketing Clostridium
Tests
Major Companies Developing or Marketing Coronavirus
Tests
Major Companies Developing or Marketing Cryptosporidium
Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus
Tests
Major Companies Developing or Marketing Enterovirus
Tests
Major Companies Developing or Marketing EBV Tests

Major Companies Developing or Marketing Giardia
Tests
Major Companies Developing or Marketing Gonorrhea
Tests
Major Companies Developing or Marketing Hantavirus
Tests
Major Companies Developing or Marketing Helicobacter
Pylori Tests
Major Companies Developing or Marketing Hepatitis
Tests
Major Companies Developing or Marketing Herpes
Tests
Major Companies Developing or Marketing Influenza
Tests
Major Companies Developing or Marketing Legionella
Tests
Major Companies Developing or Marketing Lyme Disease
Tests
Major Companies Developing or Marketing Lymphogranuloma
Tests
Major Companies Developing or Marketing Malaria
Tests
Major Companies Developing or Marketing Measles
Tests
Major Companies Developing or Marketing Meningitis
Tests

Major Companies Developing or Marketing Microsporidium
Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma
Tests
Major Companies Developing or Marketing Papilloma
Virus Tests
Major Companies Developing or Marketing Parvovirus
Tests
Major Companies Developing or Marketing Pneumonia
Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus
Tests
Major Companies Developing or Marketing Rubella
Tests
Major Companies Developing or Marketing Salmonella
Tests
Major Companies Developing or Marketing Septicemia
Tests
Major Companies Developing or Marketing Shigella
Tests
Major Companies Developing or Marketing Staphylococci
Tests

Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing Syphilis
Tests
Major Companies Developing or Marketing Toxoplasmosis
Tests
Major Companies Developing or Marketing Trichomonas
Tests
Major Companies Developing or Marketing Tuberculosis
Tests
Major Companies Developing or Marketing West Nile
Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A. Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Laboratories Performing Infectious Disease Tests
by Market Segment
U.S.A.
Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
U.S.A.
Commercial/Private Laboratories Performing Infectious
Disease Tests by Annual Test Volume
U.S.A.
Physician Office Laboratories Performing Infectious
Disease Tests by Practice Size
U.S.A.
All Market Segments Infectious Disease Test Volume Forecast

U.S.A.
All Market Segments Infectious Disease Test Volume by Method
U.S.A.
Hospital Laboratories Infectious Disease Test Volume Forecast
U.S.A.
Blood Banks Infectious Disease Test Volume Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Public Health Laboratories Infectious Disease Test
Volume Forecast
U.S.A.
All Market Segments Infectious Disease Diagnostics
Market Forecast
U.S.A.
Hospital Laboratories Infectious Disease Diagnostics
Market Forecast
U.S.A.
Blood Banks Infectious Disease Diagnostics Market Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Public Health Laboratories Infectious Disease
Diagnostics Market Forecast

U.S.A.
HIV or HIV I/HIV II/Combo Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HIVAg Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Western Blot/Other Confirmatory Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S.A.
Adenovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Aeromonads Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
BEA Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Blastocystis Hominis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Campylobacter Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Candida Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Chancroid Test Volume and Diagnostics Sales Forecast by Market
Segment

U.S.A.
Chlamydia Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Coronavirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Coxsackievirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Cryptosporidium Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Cyclospora Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
CMV Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
E. Coli Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Echovirus Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.
Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
EBV Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Giardia Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Gonorrhea Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Granuloma Inguinale Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Hantavirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Helicobacter Pylori Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HCV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HCV NAT Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.
Hepatitis C Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Anti-HBC Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Anti-HBS Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Anti-HAV Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Hepatitis Delta Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HBcAg Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
HBeAg Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
ALT/SGPT Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment

U.S.A.
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Influenza Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Legionella Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Lyme Disease Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Lymphogranuloma Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Malaria Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Measles Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Meningitis Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Microsporidium Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Mononucleosis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Mumps Test Volume and Diagnostics Sales Forecast by Market
Segment

U.S.A.
Mycoplasma Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Papilloma Virus Test Volume and Diagnostics Sales
Forecast by Market Segment
U.s.a.
Parvovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Pneumonia Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Polyomaviruses Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Pseudomonas Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Rabies
Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
RSV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Rotavirus Test Volume and Diagnostics Sales Forecast by Market
Segment

U.S.A.
Rubella Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Shigella Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
Staphylococci Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Streptococci Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Syphilis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Trichomonas Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Tuberculosis Test Volume and Diagnostics Sales Forecast by
Market Segment

U.S.A.
Vibrio Test Volume and Diagnostics Sales Forecast by Market
Segment
U.S.A.
West Nile Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Yersinia Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
AIDS Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Adenovirus Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Campylobacter Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Candida Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Chancroid Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Chlamydia Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
CMV Testing Market Diagnostics Sales by Major
Supplier

U.S.A.
Cryptosporidium Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Echovirus Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Enterovirus Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
EBV Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Giardia Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Gonorrhea Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Helicobacter Pylori Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Hepatitis Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Hepatitis C Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Herpes Testing Market Diagnostics Sales
by Major Supplier

U.S.A.
Influenza Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Legionella Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Lyme Disease Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Measles Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Meningitis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Mononucleosis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Mumps Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Mycoplasma Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Pneumonia Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Rabies Testing Market Diagnostics Sales
by Major Supplier

U.S.A.
RSV Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Rotavirus Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Rubella Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Salmonella Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Septicemia Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Shigella Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Streptococci Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Syphilis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Toxoplasmosis Testing Market Diagnostics Sales
by Major Supplier

2024 U.S. Breast Cancer Diagnostics Market

2024 U.S. Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment

USD 2450 View Report

U.S. Molecular Diagnostics Market Opportunities

2023-2028 U.S. Molecular Diagnostics Market Opportunities--2023 Competitor Shares and Growth Strategies, Five-Year Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests--Latest Technologies and Instrumentation Pipeline,

USD 3850 View Report

U.S. Virology Bacteriology Tests Supplier Shares

2023-2028 U.S. Virology and Bacteriology Database: 100 Tests, Supplier Shares, Test Volume and Sales Segment ForecastsThis database from provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for

USD 2750 View Report

U.S. Virology Bacteriology Parasitology

2023-2028 U.S. Virology, Bacteriology, Parasitology and Mycology Testing Market--Growth Opportunities, 2023 Supplier Shares by Test, 2023-2028 Centralized and POC Volume and Sales Forecasts for 100 Respiratory, STD, Enteric, and other

USD View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available